Haoxi Health Technology Down 75% After $12M Offering

Dow Jones09-20
 

By Josh Beckerman

 

Haoxi Health Technology shares fell to their lowest point yet after the company reported the pricing of a $12 million equity offering.

The stock was recently down 75% to 76 cents, with an intraday low of 60 cents. Haoxi Health Technology's January initial public offering of 2.4 million shares priced at $4 each.

Haoxi Health Technology, which provides healthcare-focused online marketing services in China, said Thursday that it sold 4 million units for $3 each.

Each unit consists of one share or pre-funded warrant, one Series A warrant and one Series B warrant.

The Series A warrant is exercisable immediately upon issuance, while the Series B warrant is exercisable on or after the 16th calendar day from closing. On the Series B exercise date, the maximum number of shares issuable upon exercise of the Series A warrant will be adjusted to 20 million.

The maximum number of shares issuable upon exercise of the Series B warrants will be 16 million.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

September 19, 2024 15:05 ET (19:05 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment